Floatz logo

Therapeutic Asset Ratings

625 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
FLUOROURACILUM
malignant pleural mesothelioma
Memorial Sloan Kettering Cancer CenterP2B (60)
FLUOROURACILUM
Urothelial Carcinoma
Memorial Sloan Kettering Cancer CenterP2B (60)
FUROSEMIDE
Myelodysplastic Syndrome
Memorial Sloan Kettering Cancer CenterP2B (60)
Hpc, Cord Blood
acute lymphoblastic leukemia
Memorial Sloan Kettering Cancer CenterP2B (60)
Pembrolizumab
angiosarcoma
Memorial Sloan Kettering Cancer CenterP2B (60)
Trastuzumab Emtansine
lymphoma
Memorial Sloan Kettering Cancer CenterP2B (60)
Mechlorethamine
lymphoma
Memorial Sloan Kettering Cancer CenterP3B (59)
Clofarabine
myeloproliferative neoplasm
Memorial Sloan Kettering Cancer CenterP2B (59)
Clofarabine
graft versus host disease
Memorial Sloan Kettering Cancer CenterP2B (59)
Clofarabine
Hodgkins lymphoma
Memorial Sloan Kettering Cancer CenterP2B (59)
Clofarabine
lymphoma
Memorial Sloan Kettering Cancer CenterP2B (59)
Monomethyl Fumarate
Thalassemia
Memorial Sloan Kettering Cancer CenterP2B (59)
Nivolumab
Gastroesophageal Adenocarcinoma
Memorial Sloan Kettering Cancer CenterP2B (59)
Datopotamab Deruxtecan
non-small cell lung carcinoma
Memorial Sloan Kettering Cancer CenterP3B (58)
Enzalutamide
breast cancer
Memorial Sloan Kettering Cancer CenterP3B (58)
Bms-907351
metastatic malignant neoplasm in the brain
Memorial Sloan Kettering Cancer CenterP2B (58)
CYCLOSPORIN A
hemoglobinopathy
Memorial Sloan Kettering Cancer CenterP2B (58)
Ipilimumab
gastroesophageal adenocarcinoma
Memorial Sloan Kettering Cancer CenterP1/2B (58)
Zirconium Zr 89 Crefmirlimab Berdoxam
non-small cell lung carcinoma
Memorial Sloan Kettering Cancer CenterP2/3B (58)
Palifermin
leukemia
Memorial Sloan Kettering Cancer CenterP3B (57)
Benadryl
Mesothelioma
Memorial Sloan Kettering Cancer CenterP2B (57)
Brentuximab Vedotin
lymphomatoid papulosis
Memorial Sloan Kettering Cancer CenterP2B (57)
Cyclophosphamide
beta thalassemia
Memorial Sloan Kettering Cancer CenterP2B (57)
DEXAMETHASONE
solitary osseous plasmacytoma
Memorial Sloan Kettering Cancer CenterP2B (57)
Epirubicin
NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)
Memorial Sloan Kettering Cancer CenterP2B (57)
Showing 101 to 125 of 625 assets
PreviousPage 5 of 25Next